Download presentation
Presentation is loading. Please wait.
Published byYildiz Sökmen Modified over 5 years ago
1
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia Patients Mithun Vinod Shah, Rima M. Saliba, Jeffrey L. Jorgensen, Sa A. Wang, Amin M. Alousi, Borje S. Andersson, Qaiser Bashir, Stefan O. Ciurea, Partow Kebriaei, David Marin, Keyur P. Patel, Uday R. Popat, Katy Rezvani, Gabriela Rondon, Elizabeth J. Shpall, Richard E. Champlin, Betul Oran Biology of Blood and Marrow Transplantation Volume 23, Issue 3, Pages S40-S41 (March 2017) DOI: /j.bbmt Copyright © Terms and Conditions
2
Figure 1 Prognostic model for 1-year relapse incidence in AML patients after SCT. Biology of Blood and Marrow Transplantation , S40-S41DOI: ( /j.bbmt ) Copyright © Terms and Conditions
3
Figure 2 (A) Cumulative 1-year relapse incidence post-SCT; (B) Cumulative proportion of patients surviving at 1 year. Biology of Blood and Marrow Transplantation , S40-S41DOI: ( /j.bbmt ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.